Peritoneal dialysis

Scholars say the change encouraged by Medicare, which spends more than $29 billion a year to treat kidney failure, can cut annual health care costs by as much as $20,000 per patient. About 8 percent to 9 percent of American kidney patients on dialysis receive the treatment at home, up from about 5 percent a decade ago, said Dr. Jeffrey S. Berns, an associate dean in graduate medical education at the University of Pennsylvania in Philadelphia. 

The influence of high peritonitis rate (HPR) on clinical outcomes of continuous ambulatory peritoneal dialysis (CAPD) patients has been far less studied in the Chinese population than in those of the USA, Australia and Europe. Furthermore, concerning the peritonitis risk, most studies primarily examined the risk of developing the first peritonitis episode, rather than a HPR.

I am in end stage renal disease and I do peritoneal dialysis daily. My biggest problem is not being able to eat due to having a very bad taste in my mouth. Nothing tastes good to me anymore. How do I get rid of the bad taste in my mouth?

Peritoneal dialysis (PD) for endstage renal failure was first given as intermittent intensive treatments (IPD) given continuously for 1-2 days once weekly. Patients would generally have a new rigid PD catheter inserted each week under local anaesthetic, be treated for up to 48h, then receive no dialysis for 5 days.

I have kidney disease and only 15% kidney function is working. My blood test show high potassium 6.5. My doctor recommends peritoneal dialysis. Should I use peritoneal dialysis now?

Hyponatremia is a surrogate marker of poor outcome in peritoneal dialysis-related peritonitis - up-to-the-minute news and headlines. 7thSpace is a online portal covering topics such as Family, Business, Entertainment, Headlines, Recipes and more. A place for the whole family featuring many different sections to chose from.

There was over a 2 fold increase in patient survival in incident peritoneal dialysis patients in the first year on dialysis compared to propensity matched incident hemodialysis patients.

Continuous Ambulatory Peritoneal dialysis (CAPD) has been promoted to be the main method of treatment for Thai End-Stage Renal Disease (ESRD) patients; however, a national survey of dialysis centers reported an annual incidence of black-stained particle of 57.6 per 1,000 CAPD cases. The objective of this study was to identify potential causes of the stain in the nurse practitioners'prospect.

The authors conducted a single–center, retrospective study, to investigate the effect of gastric acid suppressants and prokinetics on peritonitis development in peritoneal dialysis (PD) patients.

The study highlights that increased intraperitoneal volume (IIPV) can occur during automated peritoneal dialysis (APD). Furthermore, findings suggest that IIPV events are more frequent in tidal and small fill volume therapies.